Sarah Cannon Research Institute SCRI RC — Nashville, Tennessee

Sarah Cannon Research Institute SCRI RC is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute SCRI RC has participated in 1 clinical trials.

Therapeutic areas: Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute SCRI RC?

Sarah Cannon Research Institute SCRI RC has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute SCRI RC conducted?

Sarah Cannon Research Institute SCRI RC has 1 clinical trials on record. Their work covers Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer.

Is Sarah Cannon Research Institute SCRI RC accredited by Crixeo Health?

Sarah Cannon Research Institute SCRI RC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute SCRI RC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.